TAP blocks and pain relief after a tummy tuck: what the evidence shows

A tummy tuck (abdominoplasty) can involve a long incision, removal of excess skin and fat, and sometimes tightening of the abdominal muscles. Pain after surgery can make movement and deep breathing difficult. A transversus abdominis plane (TAP) block is a regional anaesthetic technique intended to numb nerves supplying the front and side of the abdominal wall. The practical question is whether adding this block to the rest of a pain-control plan makes recovery more comfortable, and what the available research can actually establish.

What the evidence found

The most directly relevant source is a 2023 systematic review and meta-analysis by Taha and colleagues. It included eight studies of abdominoplasty: five randomised trials and three observational studies. Across five studies reporting the time to first analgesic, involving 244 people, the TAP groups waited an average of 5.01 hours longer before requesting pain medicine than the comparison groups (95% confidence interval 0.90 to 9.11 hours; p=0.02). This is an average across studies, not a promise that an individual will be pain-free for five extra hours.^[1]

The review also found fewer cases of postoperative nausea or vomiting in the TAP groups in two studies (odds ratio 0.18; 95% CI 0.04 to 0.90; p=0.04). However, five studies reporting total opioid use did not show a statistically significant difference (mean difference −20.54 mg; 95% CI −46.89 to 5.81; p=0.13). The confidence interval includes no difference, so the result does not establish that TAP blocks reduce total opioid consumption. The review's abstract wording about the timing outcome is internally inconsistent; its results section and pooled estimate indicate a longer time to first analgesic with TAP, which is the interpretation used here.

How a TAP block fits into pain control

The anaesthetic is placed in a tissue plane between abdominal wall muscles, where it can temporarily interrupt sensory signals from nerves supplying the abdominal wall. It does not remove the surgical cause of pain, numb every source of discomfort, or replace the broader anaesthetic and postoperative plan. A block may be given with ultrasound guidance or, in some studies, by direct surgical access; the timing, approach, local anaesthetic and additional medicines differ between protocols.

That variation matters. A TAP block is one possible part of multimodal analgesia, which can combine regional anaesthesia with other medicines and measures selected by the clinical team. The review does not identify one universally best regimen or show that every patient needs a block. Any proposed anaesthetic plan should be confirmed with the responsible healthcare professionals.

What the review included

Taha et al. followed PRISMA reporting guidance and searched MEDLINE, Embase, Google Scholar, CINAHL and the Cochrane Central Register of Controlled Trials, as well as ClinicalTrials.gov. The search, restricted to English-language studies, ran to 4 March 2023. Eligible reports compared TAP block with no TAP block in people undergoing abdominoplasty; procedures that also involved liposuction were allowed, and both ultrasound-guided and direct techniques could be included. The authors used a random-effects model and assessed observational studies with the Newcastle–Ottawa Scale and randomised trials with the Cochrane risk-of-bias tool.^[1]

The eight included studies were published between 2010 and 2021. They covered conventional abdominoplasty, procedures with rectus plication, and lipoabdominoplasty. The review's study table lists different local anaesthetics and comparators, including saline, local anaesthetic infiltration and other nerve-block approaches. The table reports group sizes study by study; it does not provide one single overall participant total for every outcome, because not all studies contributed data to each analysis. Five studies contributed to the time-to-first-analgesic analysis (244 participants), five to total opioid use, two to nausea or vomiting, and five reported pain scores using differing scales.

A three-group randomised trial

One of the primary studies included by the review was Salama’s randomised trial at Tanta University in Egypt. It was a prospective, single-centre randomised study conducted through the Department of Anesthesia and Surgical ICU at Tanta University, Egypt, enrolling between November 2016 and December 2017. It enrolled 90 women aged 25–50 years with ASA physical status I or II and assigned 30 to each of three groups: saline wound infusion as control, continuous bilateral ultrasound-guided TAP block with 0.25% levobupivacaine, or continuous wound infusion with 0.25% levobupivacaine. The study excluded, among others, people with BMI above 35 kg/m², hepatic disease, allergy to study drugs or chronic preoperative opioid use. The primary outcome was morphine use in the first 48 hours; the investigators also recorded numerical rating scale (NRS, 0 = no pain and 10 = severe, intolerable pain) at rest and with movement, time to the first morphine dose, and time to first ambulation.^[2]

Mean 48-hour morphine use was 61.9 ± 12.8 mg in the saline-control group, 18.9 ± 8.1 mg in the TAP group and 21.5 ± 9.5 mg in the wound-infusion group (overall p=0.001). TAP and wound infusion were not significantly different from one another (p=0.259). Both active regimens delayed the first morphine dose compared with control: 8.9 ± 1.4 hours for TAP and 6.5 ± 1.7 hours for wound infusion, versus 1.2 ± 0.3 hours for control. First ambulation occurred at 6.9 ± 3.4 hours with TAP and 7.8 ± 3.1 hours with wound infusion, versus 13.2 ± 4.9 hours with control (reported p=0.001). Movement-related NRS scores were higher in the control group during the first 24 hours; the abstract does not give the corresponding numerical score differences. These results suggest that both continuous local anaesthetic approaches outperformed saline in this trial, while it did not show a clear advantage of TAP over wound infusion. They do not establish broader or longer-term recovery effects.

The trial was small, single-centre and limited to women; its protocol used continuous catheters rather than a single injection, so it should not be treated as interchangeable with every TAP technique. The accessible report gives means and standard deviations and p values for these comparisons, but no confidence intervals for the group differences. The observed result also compares complete pain-control regimens, not the block in isolation from all other care.^[2]

A small comparative pilot

Fiala’s pilot compared 32 consecutive patients having abdominoplasty, with or without flank liposuction: 16 received an open TAP block and 16 received pararectus injections plus ilioinguinal/iliohypogastric nerve blocks. Both groups also received bupivacaine injection into the rectus plication. During the first 16 hours after surgery, mean hydromorphone use was 2.63 mg in the TAP group versus 4.31 mg in the comparison group (p=0.024), and time to the first request for as-needed analgesia averaged 3 hours 11 minutes versus 1 hour 27 minutes (p=0.022). The PubMed abstract does not report confidence intervals. Because this was a small pilot, it offers preliminary comparative evidence rather than a definitive estimate; its open technique and comparator also differ from the ultrasound-guided continuous block tested by Salama.^[3]

How to interpret the pain and medication results

The pain-score findings pointed in the same direction, but could not be pooled as one common measure. Five reports used visual or related pain scales, with differences in scale and assessment time. For example, one trial reported 12-hour pain on a 0-to-3 scale as 1.2 with TAP versus 1.5 without it (p<0.001). Other reports assessed pain at rest or during movement: one reported lower scores at four hours on an 11-point scale, and another reported lower pain during mobilisation. These individual results are not directly interchangeable, and they do not show how a particular person will feel throughout recovery.

Analgesic use is also more complicated than a single pooled number. Five studies found no statistically significant difference in total opioid amount, and the pooled estimate was imprecise. The count of opioid tablets was likewise not significantly different in the two studies reporting it (mean difference −1.53 tablets; 95% CI −3.17 to 0.12; p=0.07). The review found no statistically significant change in operating time in three studies (mean difference −30.86 minutes; 95% CI −75.80 to 14.07; p=0.18). Its results section describes hospital stay and mobilisation as outcomes of interest but does not provide a pooled estimate for either. These outcomes should not be presented as proven benefits on the basis of this analysis.

Limitations and unanswered questions

Eight small studies are a narrow evidence base. Three were observational, which are more vulnerable to differences between patients who did and did not receive a block. The review rated the observational studies at seven stars on the Newcastle–Ottawa Scale and noted poor comparability. In the randomised studies, the review identified concerns about blinding: participants and clinicians could not generally be blinded to the procedure, and some reports did not describe how outcome assessors were blinded. The authors also reported substantial heterogeneity for several measures, including total opioid use and pill counts.

Block location, guidance, timing, drug and dose were not standardised across studies. Operations and accompanying procedures varied, as did the pain scales and the times at which they were recorded. The search included only English-language studies and ended in March 2023, so this review does not cover later research. It cannot determine which TAP approach works best, whether effects persist beyond the reported postoperative observation periods, or whether the same results apply to every surgical setting or patient group. Larger, well-designed trials using consistent techniques and outcomes are needed. For cost planning, see the site's page on tummy tuck cost in Turkey; the price information does not explain how postoperative pain will be managed.

Questions to ask the clinical team

• Is a TAP block being considered for my operation, and who would perform it?
• Would it be ultrasound-guided or delivered during surgery, and what are the expected benefits and limitations of that approach?
• What other pain-relief measures are planned, and how will they work alongside the block?
• How will pain be assessed at rest and during movement, and what is the plan if pain relief is inadequate?
• What side effects or risks apply to the medicines and regional anaesthesia proposed for me?
• What monitoring and follow-up are available after discharge, and whom should I contact with a concern?

When discussing practical arrangements, ask the responsible professionals to explain the anaesthetic plan and follow-up directly. If you are reviewing what a package describes, the site's tummy tuck package information can help frame questions about inclusions; it does not establish that a TAP block is included or appropriate. These are discussion prompts, not personal medical advice. Just Clinic Istanbul is an independent marketing and lead-generation platform, not a healthcare provider or medical tourism intermediary. Enquiries may be shared with authorised healthcare partners with your consent.

References

1. Taha N, Hodson L, Tong K, Zahari F, Hoo ZL, Wong YW, Rahman S. The Efficacy of the Transversus Abdominis Plane Block in Abdominoplasty: A Systematic Review and Meta-Analysis. Cureus. 2023;15(11):e48992. Published 18 November 2023. doi:10.7759/cureus.48992. PMID:38111414. PubMed record · Open full text.
2. Eman Ramadan Salama. Post-operative bilateral continuous ultrasound-guided transversus abdominis plane block versus continuous local anaesthetic wound infusion in patients undergoing abdominoplasty. Indian Journal of Anaesthesia. 2018;62(6):449–454. doi:10.4103/ija.IJA_221_18. PMID:29962527. PubMed record · Open full text.
3. Fiala T. Tranversus abdominis plane block during abdominoplasty to improve postoperative patient comfort. Aesthetic Surgery Journal. 2015;35(1):72–80. doi:10.1093/asj/sju019. PMID:25536505. PubMed record.